top of page

Annovis Bio Founder & CEO Maria Maccecchini shares an update on the oral small molecule buntanetap, which is currently in a pivotal trial for Alzheimer's

  • blonca9
  • 14 minutes ago
  • 1 min read

She describes the mechanism of the drug, which she says is capable of inhibiting multiple types of diseases proteins in the brain. Plus, an update on the enrollment and timeline of the company's phase three study that is ongoing.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page